lung cancer

2018 ASCO Annual Meeting; #ASCO18
June 2, 2018 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are at the 2018 ASCO Annual Meeting. Today’s key research highlights address the connection between microsatellite instability and Lynch syndrome, a blood test that may be used to find early lung cancer, a new targeted therapy for treating advanced breast cancer, an immunotherapy-chemotherapy combination that slows lung cancer growth, and evidence that personalized medicine helps people with cancer live longer. Read More >>
2018 ASCO Annual Meeting; #ASCO18
May 16, 2018 · Monika Sharda, ASCO staff
Read key research highlights that will be presented at the 2018 ASCO Annual Meeting, including monitoring symptoms with technology, screening and genomic testing for lung cancer, and new treatment regimens for breast cancer and T-cell leukemia and lymphoma. Read More >>
Palliative and Supportive Care in Oncology Symposium: Patient-centered care across the cancer continuum
October 23, 2017 · Greg Guthrie, ASCO staff
Research highlights from the Palliative and Supportive Care in Oncology Symposium address computers in exam rooms, doctor and patient views of prognosis and cure, having patients and caregivers practice yoga together, and resilience training in adolescents and young adults. Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 5, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Today’s key research highlights include CAR T-cell therapy for multiple myeloma, immune checkpoint inhibitors for mesothelioma, and targeted therapy advances for non-small cell lung cancer and HER2-positive breast cancer. Read More >>
2017 ASCO Annual Meeting. #ASCO17
June 4, 2017 · Greg Guthrie, ASCO staff
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer. Read More >>

Pages